This inventor holds 2 USPTO granted patents. Top assignee: Liplasome Pharma A/s. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Odorse, DK (2007)
- Klampenborg, DK (2008)
Company Filing History:
Years Active: 2007-2008
Title: Ole G Mouritsen: Innovator in Lipid-Based Drug Delivery Systems
Introduction
Ole G Mouritsen is a prominent inventor based in Klampenborg, Denmark. He has made significant contributions to the field of lipid-based drug delivery systems, focusing on innovative solutions for diagnosing and treating various medical conditions. With a total of 2 patents, Mouritsen's work is paving the way for advancements in medical diagnostics and therapeutics.
Latest Patents
Mouritsen's latest patents include "Lipid-based systems for targeting diagnostic agents" and "Lipid-based drug delivery systems against parasitic infections." The first patent relates to the targeting of diagnostic agents using lipid-based compositions, which are particularly useful in diagnosing disorders associated with increased levels of extracellular PLA activity in diseased tissues, such as cancer and inflammatory conditions. The second patent focuses on a lipid-based delivery system for administering active drug substances, specifically lysolipid derivatives, which are effective in treating or detecting parasitic infections that elevate PLA levels in infected mammals.
Career Highlights
Throughout his career, Ole G Mouritsen has been associated with Liplasome Pharma A/S, where he has been instrumental in developing innovative lipid-based therapies. His expertise in lipid science has positioned him as a key figure in the pharmaceutical industry, contributing to advancements that address critical health challenges.
Collaborations
Mouritsen has collaborated with notable colleagues, including Kent Jørgensen and Jesper Davidsen, to further enhance the research and development of lipid-based drug delivery systems. Their combined efforts have led to significant progress in the field.
Conclusion
Ole G Mouritsen's innovative work in lipid-based drug delivery systems exemplifies the impact of scientific research on medical advancements. His patents and collaborations continue to contribute to the development of effective diagnostic and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile